Breast implant illness, commonly shortened to BII, is the name patients and clinicians use for a broad group of systemic symptoms reported by some people with breast implants. The symptoms are real. The difficult part is that BII does not yet have a single diagnostic test, accepted case definition, or proven mechanism that explains every patient.
That uncertainty should not be used to dismiss a patient, and it should not be replaced with a guarantee that explant surgery will cure every symptom. Dr. Ruben Castro uses an evidence-first conversation in Newport Beach: listen carefully, evaluate other medical causes, examine the implants and breasts, and define what surgery can and cannot reasonably address.
What Symptoms Are Commonly Reported?
Reports include fatigue, brain fog, memory or concentration problems, joint and muscle pain, rashes, hair changes, headaches, anxiety, depression, sleep problems, gastrointestinal complaints, and a general sense of inflammation or poor health. Symptoms have been reported with saline and silicone implants, and with different shapes and surface types.
These symptoms are not specific to implants. Thyroid disease, anemia, autoimmune conditions, perimenopause, sleep disorders, infection, medication effects, nutritional deficiencies, depression, and other conditions can create overlapping patterns. A surgical consultation should not replace primary care or specialty evaluation when the history suggests another cause.
What Does the FDA Say About BII?
The U.S. Food and Drug Administration states that BII is not recognized as a formal medical diagnosis and that its cause and relationship to implants remain unclear. The agency has received thousands of medical device reports describing systemic symptoms. These reports are important for surveillance, but they cannot establish incidence or causation because reporting is passive, may contain duplicates, and lacks a comparison population.
The FDA also notes that some patients report partial or complete improvement after implant removal. That observation supports taking symptoms seriously, but it does not predict an individual outcome.
What Do Explant Studies Show?
Several observational studies and systematic reviews report symptom improvement in many patients after explantation. A 2024 systematic review found improvement reported across multiple studies, while a prospective ASERF investigation found sustained improvement in the symptomatic cohort.
These studies do not prove that every symptom was caused by an implant. People who choose explant are a selected group, symptom reporting is subjective, procedures vary, and placebo, expectation, natural symptom fluctuation, concurrent treatment, or other factors can influence outcomes. The evidence supports a balanced statement: improvement is possible and commonly reported in selected cohorts, but complete, permanent relief cannot be promised.
Does the Entire Capsule Need to Be Removed?
The capsule is the scar tissue the body forms around every implant. Capsulectomy may be appropriate for capsular contracture, rupture with silicone involvement, calcification, suspicious findings, or when access and safety support removal. The ASERF study found symptom improvement was not dependent on the type of capsulectomy performed.
An en bloc capsulectomy means removing the implant and capsule together without intentionally opening the capsule. It is an oncologic term that is technically possible only when the capsule and surrounding anatomy allow it. It is not automatically required for systemic symptoms. More aggressive capsule removal can increase bleeding, pneumothorax, contour change, and injury to the chest wall, especially when the capsule is thin and adherent.
The existing guide to implant removal without replacement explains the differences among explant, partial capsulectomy, total capsulectomy, and en bloc removal.
BII Is Different from Rupture, Contracture, and Implant-Associated Cancer
BII describes systemic symptoms. A silicone or saline rupture is a device-shell problem. Capsular contracture is tightening of scar tissue that can cause firmness, distortion, or pain.
BIA-ALCL and other rare implant-associated malignancies are separate diagnoses with specific warning signs and workups. Late breast swelling, a new fluid collection, mass, persistent one-sided pain, enlarged nodes, or a major shape change should be evaluated promptly. These conditions should not be labeled BII without assessment.
What an Evaluation Should Include
Bring implant cards, operative reports, prior imaging, a symptom timeline, current medications, and relevant medical testing when available. The examination looks for rupture, contracture, asymmetry, pain, fluid, masses, skin change, and the condition of the breast after potential implant removal.
Dr. Castro may recommend imaging or coordination with primary care, rheumatology, endocrinology, or another clinician depending on the symptoms. Evaluation is not a test of whether a patient is believed. It is a way to avoid missing a treatable condition and to make surgical consent more accurate.
What Explant Can and Cannot Change Aesthetically
Removing an implant reduces volume. The remaining breast may look deflated, lower, asymmetric, or indented, especially after large implants, pregnancy, weight change, thin tissue, or contracture. A breast lift can reshape and elevate tissue, while fat grafting may add modest volume in selected patients. Either adds its own scars, recovery, limits, and risks.
Some patients want the smallest operation and accept looseness. Others prioritize shape and consider a lift. The right plan should not be used to sell a larger operation during a vulnerable decision.
Frequently Asked Questions
Is there a blood test for BII? No single validated test confirms or excludes BII. Testing may be appropriate to evaluate other diagnoses based on symptoms.
Will explant cure my fatigue or joint pain? It may improve symptoms, and many studies report improvement, but there is no reliable way to guarantee which symptoms will change or by how much.
Must my capsule be removed en bloc? No. Capsule management depends on contracture, rupture, suspicious findings, anatomy, and safety. En bloc removal is not a universal treatment for systemic symptoms.
Should a person without symptoms remove implants preventively? Routine removal is not automatically recommended solely because an implant is present. Implant age, device type, imaging, symptoms, and preferences belong in an individualized discussion.
Discuss BII and Explant Options in Newport Beach
Dr. Ruben Castro can review symptoms without dismissing them or promising a cure. In a Newport Beach consultation, he can evaluate the breasts and implants, coordinate appropriate workup, explain implant exchange or removal options, and build a conservative plan around the patient's priorities and safety.
